Lionett S: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) (Created page with "{{person}}") Β |
Beno Marija (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{ | {{Person | ||
|lastname=Lionett | |||
|firstname=Sofie | |||
|institution=Mary Mackillop Institute for Health Research, | |||
|address=Level 5 on 215 Spring Street | |||
|area code=3000,VIC | |||
|city=Melbourne | |||
|country=Australia | |||
}} | |||
{{Labelingperson}} |
Revision as of 15:18, 8 November 2018
Name | Lionett Sofie, |
---|---|
Institution | Mary Mackillop Institute for Health Research, |
Address | Level 5 on 215 Spring Street, 3000,VIC |
City | Melbourne |
State/Province | |
Country | Australia |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Kiel 2020 BMJ Open | 2020 | Kiel IA, Lionett S, Parr EB, Jones H, RΓΈset MAH, Salvesen Γ, Vanky E, Moholdt T (2020) Improving reproductive function in women with polycystic ovary syndrome with high-intensity interval training (IMPROV-IT): study protocol for a two-centre, three-armed randomised controlled trial. BMJ Open 10:e034733. |